Home > News > The story of a nanotechnology start-up
July 30th, 2007
The story of a nanotechnology start-up
Abstract:
PharmaTelevision talks to Professor Tom Rademacher a professor at University College London (UCL)'s Immunology & Molecular Pathology Department, and President of Midatech, about the formation of the Midatech, Professor Rademacher's fifth start-up company. Midatech is focused on exploring the possibilities of nanotechnology, particularly for medical therapeutic and diagnostic applications.
Specifically, the company is a manufacturer of biocompatible nanoparticles called nanocells. They possess a number of unique properties that make them ideal for therapeutics, diagnostics and other enabling applications.
Source:
nanowerk.com
Bookmark:
| Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Human Interest/Art
Drawing data in nanometer scale September 30th, 2022
Scientists prepare for the world’s smallest race: Nanocar Race II March 18th, 2022
Graphene nanotubes revolutionize touch screen use for prosthetic hands August 3rd, 2021
JEOL Announces 2020 Microscopy Image Grand Prize Winners January 7th, 2021
Nanobiotechnology
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||